Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E V Privalova

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Kardiologiia|August 20, 2013
[Hypertrophic cardiomyopathy -- modern state of the problem. Issues of epidemiology and nomenclature, genetics and pathophysiology, variants of course and differential diagnosis]Iu N Belenkov, E V Privalova, V Iu Kaplunova, et al.
Kardiologiia|August 9, 2014
[Renin-angiotensin-aldosterone system in hypertrophic cardiomyopathy]M V Kozhevnikova, V Iu Kaplunova, E V Privalova, et al.
Kardiologiia|April 8, 2025
WNT Signaling Cascade Proteins and Structural and Functional State of The Vascular Bed in Patients With Various Phenotypes of Stable Ischemic Heart DiseaseA O Iusupova, N N Pakhtusov, O A Slepova, et al.
Kardiologiia|December 15, 2012
[Contemporary trends of genetic analysis in hypertrophic cardiomyopathy]Iu N Belenkov, E V Privalova, V Iu Kaplunova, et al.
Kardiologiia|March 18, 2021
Endothelial dysfunction and inflammation in patients with non-obstructive coronary arteriesN N Pakhtusov, A O Iusupova, E V Privalova, et al.
Kardiologiia|March 11, 2022
Characteristic of cardiovascular status and intracardiac hemodynamics in patients with multiple myeloma before the start of antitumor therapyS A Kardanova, I S Ilgisonis, V I Ershov, et al.
Kardiologiia|December 29, 2025
The Influence of Tumor-Associated Systemic Inflammation on Vascular Remodeling in Oncohematological Patients Before Antitumor TherapyD A Kutsakina, N V Khabarova, E V Privalova, et al.
Klinicheskaia Meditsina|October 10, 2018
[Modern approaches to the problem of hypertrophic cardiomyopathy]V Yu Kaplunova, G A Shakar'yants, M V Kozhevnikova, et al.
Kardiologiia|September 2, 2014
[Matrix metalloproteinases and hypertrophic cardiomyopathy]E V Privalova, V Iu Kaplunova, M V Kozhevnikova, et al.
Kardiologiia|May 13, 2020
[E-Selectin as a Marker of Endothelial Dysfunction in Patients with Coronary Artery Disease Including Those with Type 2 Diabetes Mellitus]A V Zhito, A O Iusupova, M V Kozhevnikova, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Kardiologiia|August 20, 2013
[Hypertrophic cardiomyopathy -- modern state of the problem. Issues of epidemiology and nomenclature, genetics and pathophysiology, variants of course and differential diagnosis]Iu N Belenkov, E V Privalova, V Iu Kaplunova, et al.
Kardiologiia|August 9, 2014
[Renin-angiotensin-aldosterone system in hypertrophic cardiomyopathy]M V Kozhevnikova, V Iu Kaplunova, E V Privalova, et al.
Kardiologiia|April 8, 2025
WNT Signaling Cascade Proteins and Structural and Functional State of The Vascular Bed in Patients With Various Phenotypes of Stable Ischemic Heart DiseaseA O Iusupova, N N Pakhtusov, O A Slepova, et al.
Kardiologiia|December 15, 2012
[Contemporary trends of genetic analysis in hypertrophic cardiomyopathy]Iu N Belenkov, E V Privalova, V Iu Kaplunova, et al.
Kardiologiia|March 18, 2021
Endothelial dysfunction and inflammation in patients with non-obstructive coronary arteriesN N Pakhtusov, A O Iusupova, E V Privalova, et al.
Kardiologiia|March 11, 2022
Characteristic of cardiovascular status and intracardiac hemodynamics in patients with multiple myeloma before the start of antitumor therapyS A Kardanova, I S Ilgisonis, V I Ershov, et al.
Kardiologiia|December 29, 2025
The Influence of Tumor-Associated Systemic Inflammation on Vascular Remodeling in Oncohematological Patients Before Antitumor TherapyD A Kutsakina, N V Khabarova, E V Privalova, et al.
Klinicheskaia Meditsina|October 10, 2018
[Modern approaches to the problem of hypertrophic cardiomyopathy]V Yu Kaplunova, G A Shakar'yants, M V Kozhevnikova, et al.
Kardiologiia|September 2, 2014
[Matrix metalloproteinases and hypertrophic cardiomyopathy]E V Privalova, V Iu Kaplunova, M V Kozhevnikova, et al.
Kardiologiia|May 13, 2020
[E-Selectin as a Marker of Endothelial Dysfunction in Patients with Coronary Artery Disease Including Those with Type 2 Diabetes Mellitus]A V Zhito, A O Iusupova, M V Kozhevnikova, et al.
Pageof 6